Articles by Katie Anderson

1. FDA Publishes 200+ CRLs For Increased Transparency 7/16/2025

   The letters were made available to increase transparency and help sponsors reduce similar mistakes in the future.

2. Can AMTs Make U.S. Pharmaceuticals Faster, Better, Stronger? 7/11/2025

   As the pharmaceutical industry prepares for impending tariffs and invests in domestic manufacturing, advanced manufacturing technologies present a viable opportunity to modernize systems for improved efficiency, consistent quality and potentially lower costs.

3. Researchers Switch Up Paracetamol Production With Eco Method 7/2/2025

   Scientists at the University of Edinburgh’s Wallace Lab developed a method to produce paracetamol that can reduce environmental pollution and the industry’s reliance on fossil fuels

4. FDA Addresses U.S. Health Crisis With Voucher Program 7/2/2025

   FDA Commissioner Marty Makary, M.D., M.P.H., tapped into his oncologist experience to launch a new FDA program designed to fast-track the time it takes for important drugs to receive approval and get to patients.

5. Lab Oversupply Is Pushing Leasing, Rent and Relocation Down 7/1/2025

   The landscape of the U.S. pharmaceutical lab market is changing, according to JLL’s U.S. Life Sciences Property Report. In addition to the effort to bring pharma manufacturing back to the U.S. ahead of looming tariffs, an oversupply of space and lower tenant demand in large biopharma markets is dropping leasing rates, rent costs and lease duration, among other changes.

6. CDER's Director Set To Retire Amid FDA Leadership Shuffle 7/1/2025

   Jacqueline Corrigan-Curay, M.D., J.D., announced plans to retire from her position as acting director of CDER, calling the decision "incredibly challenging." Corrigan-Curay is not alone in her decision to leave the FDA, with a number of leaders exiting the agency since January.